Cellzome Teaming with Pfizer to Investigate the Epigenetics of Stem Cell Regulation

The company will work with Pfizer's Pain & Sensory Disorders and Regenerative Medicine unit on the project using its Episphere chemoproteomics platform.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.